| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 10 |
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 10 |
-
|
-
|
-
| | | Operating Expenses | | Research Development | 2,465 | 2,480 | 2,492 | 3,369 | | Selling General and Administrative | 2,356 | 786 | 1,333 | 1,277 | | Non Recurring |
-
| 389 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,811) | (3,655) | (3,825) | (4,646) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (5,617) |
-
|
-
| 1 | | Earnings Before Interest And Taxes | (10,428) | (3,655) | (3,825) | (4,645) | | Interest Expense | 1,813 | 440 | 751 | 597 | | Income Before Tax | (12,241) | (4,095) | (4,576) | (5,242) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (12,241) | (4,095) | (4,576) | (5,242) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,241) | (4,095) | (4,576) | (5,242) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,241) | ($4,095) | ($4,576) | ($5,242) |
|
0.01% Nasdaq 0.00%
Income Statement
